Literature DB >> 11994906

No role of calcium- and ATP-dependent potassium channels in insulin-induced vasodilation in humans in vivo.

Evertine J Abbink1, Annabel J Walker, Henk A van der Sluijs, Cees J Tack, Paul Smits.   

Abstract

The mechanism of insulin-induced vasodilation has not been completely clarified, but could be important in future treatment strategies of insulin resistance. Recently, a role for calcium-dependent and ATP-dependent potassium (K(Ca) and K(ATP)) channels in insulin-induced vasodilation has been demonstrated in in vitro studies. A role for these channels has never been confirmed in humans in vivo. Therefore, we investigated the role of these channels in insulin-induced vasodilation in humans in vivo. A hyperinsulinemic euglycemic clamp was combined with intra-arterial infusion of placebo, tetraethylammonium (blocker of K(Ca) channels) or glibenclamide (blocker of K(ATP) channels) in three groups of 12 healthy volunteers. Bilateral forearm blood flow was measured with venous occlusion plethysmography. Systemic hyperinsulinemia induced a 20+/-9% vasodilation (p=0.001). Neither tetraethylammonium nor glibenclamide reduced this vasodilation as compared to placebo. According to the results of the present study, insulin-induced vasodilation seems not to be mediated by the opening of K(Ca) and K(ATP) channels in humans in vivo. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994906     DOI: 10.1002/dmrr.269

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  8 in total

1.  Cerebral blood flow response to hypoglycemia is altered in patients with type 1 diabetes and impaired awareness of hypoglycemia.

Authors:  Evita C Wiegers; Kirsten M Becker; Hanne M Rooijackers; Federico C von Samson-Himmelstjerna; Cees J Tack; Arend Heerschap; Bastiaan E de Galan; Marinette van der Graaf
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

2.  ATP-induced vasodilation in human skeletal muscle.

Authors:  E E M van Ginneken; P Meijer; N Verkaik; P Smits; G A Rongen
Journal:  Br J Pharmacol       Date:  2004-02-09       Impact factor: 8.739

3.  Improved pharmacokinetic and pharmacodynamic profile of rapid-acting insulin using needle-free jet injection technology.

Authors:  Elsemiek E C Engwerda; Evertine J Abbink; Cees J Tack; Bastiaan E de Galan
Journal:  Diabetes Care       Date:  2011-06-29       Impact factor: 19.112

4.  Patients with type 1 diabetes mellitus have impaired IL-1β production in response to Mycobacterium tuberculosis.

Authors:  E Lachmandas; K Thiem; C van den Heuvel; A Hijmans; B E de Galan; C J Tack; M G Netea; R van Crevel; J A van Diepen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-11-30       Impact factor: 3.267

5.  Pharmacokinetic and Pharmacodynamic Variability of Insulin When Administered by Jet Injection.

Authors:  Elsemiek E C Engwerda; Cees J Tack; Bastiaan E de Galan
Journal:  J Diabetes Sci Technol       Date:  2017-03-17

6.  Effect of short-term use of dapagliflozin on impaired awareness of hypoglycaemia in people with type 1 diabetes.

Authors:  Lian A van Meijel; Cees J Tack; Bastiaan E de Galan
Journal:  Diabetes Obes Metab       Date:  2021-08-16       Impact factor: 6.408

7.  Effect of lactate administration on brain lactate levels during hypoglycemia in patients with type 1 diabetes.

Authors:  Evita C Wiegers; Hanne M Rooijackers; Cees J Tack; Bart Wj Philips; Arend Heerschap; Marinette van der Graaf; Bastiaan E de Galan
Journal:  J Cereb Blood Flow Metab       Date:  2018-05-11       Impact factor: 6.200

8.  Effect of lactate administration on cerebral blood flow during hypoglycemia in people with type 1 diabetes.

Authors:  Evita C Wiegers; Bastiaan E de Galan; Lian A van Meijel; Jack J A van Asten; Joanes Grandjean; Arend Heerschap; Cornelis J Tack; Marinette van der Graaf
Journal:  BMJ Open Diabetes Res Care       Date:  2022-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.